BIOCON
Back to Cashflow Statement
|
BIOCON Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,994 Cr | ₹4,061 Cr | ₹2,954 Cr | ₹1,853 Cr | ₹1,177 Cr |
What is the latest Cash Flow from Operating Activities ratio of BIOCON ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,994 Cr |
| Mar2025 | ₹4,061 Cr |
| Mar2024 | ₹2,954 Cr |
| Mar2023 | ₹1,853 Cr |
| Mar2022 | ₹1,177 Cr |
How is Cash Flow from Operating Activities of BIOCON Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,994 Cr | -50.90 | |
| Mar2025 | ₹4,061 Cr | 37.49 | |
| Mar2024 | ₹2,954 Cr | 59.45 | |
| Mar2023 | ₹1,853 Cr | 57.45 | |
| Mar2022 | ₹1,177 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹59,769.2 Cr | 6.8% | 5.1% | -3.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 6.8% |
5.1% |
-3.2% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses